Skip to content

Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors

Department of Ultrasonic Medicine, The First Affiliated Hospital of Air Force Medical University

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06524557
Enrollment
200
Registered
2024-07-29
Start date
2018-01-01
Completion date
2025-12-30
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Tumor

Keywords

liver tumors, benign, malignant, Differential diagnosis

Brief summary

To explore an effective noninvasive method for differential diagnosis of liver tumors.

Detailed description

A retrospective study was performed to assess the performance of certain ultrasound-based parameters, in distinguishing benign from malignant with liver biopsy as the gold standard. Demographic data, clinical information and serological data were obtained from participants who were retrospectively enrolled. Receiver operating characteristic (ROC) curve analysis was conducted, including calculation of the optimal area under the ROC curve (AUC), to assess the performance of these measures in distinguishing between benign and malignant in patients with or without chronic liver disease.

Interventions

DIAGNOSTIC_TESTwith chronic liver disease

patients with hepatitis B virus,hepatitis C virus, or other chronic liver disease

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

(1) age 18-70 years; (2) liver examination performed for all patients prior to US-guided liver biopsy or surgery; (3) tumor can be visualized in conventional US; (4) largest tumor sectional area saved in DICOM format for use in later analyses; (5) a histopathological diagnosis made either from US-guided liver biopsy or surgical resection; (6) suitable routine clinical and US data obtained within 7 days of the histopathological diagnosis.

Exclusion criteria

(1) unavailable pathological diagnosis; (2) liver metastatic tumors; (3) poor quality US images; and (4) a past history of surgical resection, percutaneous local ablation, radiation, transarterial and systemic therapies or liver transplantation.

Design outcomes

Primary

MeasureTime frameDescription
The differential diagnosis of liver tumors2018.01-2025.12Multimodal ultrasound is of great value in the differential diagnosis of liver tumors

Countries

China

Contacts

Primary ContactZhou Huihui, M.M.
huihui2807201830@163.com15209239680

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026